My Account Log in

1 option

Tyrosine Kinases as Druggable Targets in Cancer / edited by Huan Ren.

DOAB Directory of Open Access Books Available online

View online
Format:
Book
Author/Creator:
Ren, Huan, Editor.
Contributor:
Ren, Huan, editor.
Language:
English
Subjects (All):
Oncology.
Physical Description:
1 online resource (134 pages)
Place of Publication:
IntechOpen 2019
London, United Kingdom : IntechOpen, 2019.
Language Note:
English
Summary:
Protein tyrosine kinase (PTK) deregulation contributes to growth of cancer and many other diseases. The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the deregulated PTKs, such as epidermal growth factor receptor (EGFR) in non-small-cell lung cancer (NSCLC) and Bcr-ABL in chronic myeloid leukemia (CML), has revolutionized disease management. In this book, we examine a few aspects of PTKs and cancer, considering efficacy, predictive markers to therapeutic response, limitations, and future directions in TKI treatment. In this rapidly evolving field, overcoming therapeutic resistance is most challenging, and multi-targeting directs the next-generation TKIs and combination therapy as ongoing strategies in cancer treatment.
Notes:
Description based on publisher supplied metadata and other sources.
ISBN:
9781839622199
1839622199
9781789848090
1789848091

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account